Cancer Care in the Post-Covid World: A UK and European Perspective on Learning from the Pandemic
暫譯: 後疫情時代的癌症護理：英國與歐洲對疫情學習的觀點

這本開放存取的教科書獲得英國腫瘤護理學會（UKONS）的支持，涵蓋了COVID-19疫情對癌症護理的影響，以及醫療專業人員和癌症診斷患者所受到的影響。書中討論了有關COVID與癌症的當前研究，並考慮了對實體腫瘤患者和血液惡性腫瘤患者的不同影響。作者批判性地評估了技術在應對疫情中的應用，以及對患者管理和其福祉、醫療專業人員的教育以及腫瘤癌症治療的提供所造成的影響。他們還檢視了疫情對患者和醫療專業人員的持續心理影響，並分析了疫情對癌症護理慈善部門的影響。重要的是，這本書提供了英國和歐洲的觀點，並展望評估疫情對癌症護理的長期影響，包括正面和負面影響。

Mark Foulkes has been in post as Nurse Consultant and Macmillan Lead Cancer Nurse at the Royal Berkshire Foundation Trust since 2007. He is the current President of the UK Oncology Nursing Society (UKONS). He has been a UKONS board member since 2018 where he edits the twice-monthly e-newsletter and is a board representative for the UK Lead Cancer Nurse Members Interest Group.He is a clinical member of the Acute Oncology Team and, during the COVID-19 pandemic he continued to work at the Royal Berkshire Hospital seeing patients. He also worked strategically to help manage the Trusts response to the crisis. He helped establish the Trust's staff COVID swabbing regimen and the hospital's virtual Cancer Rehabilitation sessions, which have been very successful. Mark has presented widely on a range of subjects and has a particular interest in nurse-led services, innovative approaches to cancer care delivery and the political backdrop to cancer services. He has previously co-edited the Second edition of The Oxford University Press Handbook of Oncology Nursing, as well as recently completing The Fundamentals of Cancer Care as the lead editor.
Helen Roe has been a key member of the UK Oncology Nursing Society (UKONS) for many years, including the role of Board member and President. Until the end of 2022 on a day-to-day basis she was employed as Consultant Cancer Nurse by Newcastle upon Tyne Hospitals NHS Foundation Trust, which is part of the Northern Cancer Alliance in the UK. Previously she was a Consultant Editor for the British Journal of Nursing Oncology supplement.

She worked in adult cancer care for most of her career and felt privileged to have fulfilled the role of Consultant Cancer Nurse, which enabled her to remain clinical day to day, yet also be active in research, service developments and educating others. Throughout her career she developed a wealth of skills, knowledge and expertise in patient care, leadership and service development, all of which influenced her day-to-day practice and ultimately the patient care she and others provided.

Her specialist area of clinical expertise was the management of patients with breast cancer, from receiving neo-adjuvant treatments through to end-of-life care. This involved assessing patients; managing symptoms and treatment toxicities, prescribing, requesting radiological investigations, developing and leading services and ensuring patients were offered the opportunities to take part in research. She presented at many conferences, from local to international; published extensively on an array of topics and constantly explored ways to enhance patient care throughout her career.

Dr Andreas Charalambous, BSc, MSc, PGCert (Research), PhD (Oncology Nursing), started his nursing career in 1995. He obtained his BSc in Nursing Science in 1999 by the Northumbria University (U.K), his MSc (Nursing Science) in 2002 and his PhD (Oncology Nursing) in 2008 from Middlesex University (UK). He has a proven track in academia since 2004. Ηe is the Chair of the Nursing Department at the Cyprus University of Technology where he works as an Associate Professor of Oncology and Palliative Care and he also holds the position of an Adjunct Professor at University of Turku (Finland). He is the founder and Past-President of the Cyprus Oncology Nursing Society, European Oncology Nursing Society (EONS) Past-President and European Cancer Organization President-Elect. He is also the Founder of the Cancer Nursing Fund. He is involved in National and International research programs (HORIZON2020, ERASMUS+, COST) in various fields of cancer care. Examples of externally funded projects include: PI in the ERASMUS+ project PROLEPSIS and PI (Cyprus team) in the ERAMUS+ project HERO, PI (Cyprus team) in the HORIZON project INCISIVE. He has published over 150 National and International publications in esteemed journals.

馬克·福克斯（Mark Foulkes）自2007年以來擔任皇家伯克郡基金會信託的護理顧問及麥克米倫首席癌症護理師。他目前是英國腫瘤護理學會（UKONS）的會長。自2018年以來，他一直是UKONS的董事會成員，負責編輯每月兩次的電子新聞通訊，並擔任英國首席癌症護理師成員利益小組的董事會代表。他是急性腫瘤團隊的臨床成員，在COVID-19大流行期間，他繼續在皇家伯克郡醫院工作，接診病人。他還在戰略上協助管理信託對危機的應對。他幫助建立了信託的員工COVID檢測計劃和醫院的虛擬癌症康復課程，這些都取得了很大的成功。馬克在多個主題上廣泛發表演講，特別對護理主導的服務、創新癌症護理交付方法以及癌症服務的政治背景感興趣。他曾共同編輯《牛津大學出版社腫瘤護理手冊》的第二版，並最近完成了《癌症護理基礎知識》的主編工作。

海倫·羅（Helen Roe）多年來一直是英國腫瘤護理學會（UKONS）的關鍵成員，包括擔任董事會成員和會長。直到2022年底，她在泰恩河畔紐卡斯爾醫院NHS基金會信託擔任顧問癌症護理師，該信託是英國北方癌症聯盟的一部分。她之前曾擔任《英國護理腫瘤學期刊》補充刊物的顧問編輯。

她在成人癌症護理領域工作了大部分職業生涯，並感到榮幸能夠擔任顧問癌症護理師的角色，這使她能夠保持日常臨床工作，同時也積極參與研究、服務發展和教育他人。在她的職業生涯中，她積累了豐富的技能、知識和專業知識，涵蓋病人護理、領導力和服務發展，這些都影響了她的日常實踐，最終影響了她和其他人提供的病人護理。

她的臨床專業領域是乳腺癌患者的管理，從接受新輔助治療到臨終護理。這包括評估患者；管理症狀和治療毒性，開處方，要求放射學檢查，開發和領導服務，並確保患者有機會參加研究。她在許多會議上發表演講，從地方到國際；在各種主題上廣泛發表文章，並不斷探索提升病人護理的方法。

安德烈亞斯·查拉蘭布斯博士（Dr Andreas Charalambous），學士、碩士、研究研究證書、腫瘤護理博士，自1995年開始他的護理生涯。他於1999年在英國諾森比亞大學獲得護理科學學士學位，2002年獲得護理科學碩士學位，2008年在米德爾塞克斯大學獲得腫瘤護理博士學位。他自2004年以來在學術界有著良好的表現。他是塞浦路斯科技大學護理系的主任，擔任腫瘤學和緩和護理的副教授，同時也是土耳其大學（芬蘭）的兼任教授。他是塞浦路斯腫瘤護理學會的創始人和前會長，歐洲腫瘤護理學會（EONS）前會長及歐洲癌症組織當選會長。他還是癌症護理基金的創始人。他參與了國內和國際的研究計劃（HORIZON2020、ERASMUS+、COST），涵蓋癌症護理的各個領域。外部資助項目的例子包括：ERASMUS+項目PROLEPSIS的首席研究員，以及ERASMUS+項目HERO的首席研究員（塞浦路斯團隊），HORIZON項目INCISIVE的首席研究員（塞浦路斯團隊）。他在知名期刊上發表了超過150篇國內和國際的出版物。